Maynard Um
-
-
-
-
-
-
-
Adicet Bio (ACET) is Fairly Valued - Citizens
-
-
-
-
-
-
-
Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
-
-
-
-
-
-
-
Adicet Bio (ACET) Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Adicet Bio Inc. (ACET)
-
-
-
-
-
-
-
Adicet Bio (ACET): ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
-
-
-
-
-
-
-
Adicet Bio (ACET) Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
396,336 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

